Analysis | Metabolite Name | Measured Value | Units | Treatment |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1.4 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1.4 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 14 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 25 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 28 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 30 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 36 | peak heights | Method Blank |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 123 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 124 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 130 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 143 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 144 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 151 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 152 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 165 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 175 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 184 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 185 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 188 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 213 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 221 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 255 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 258 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 269 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 271 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 274 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 286 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 368 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 438 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 553 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 575 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 636 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 648 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 790 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 808 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 815 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 821 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 821 | peak heights | Pool QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 838 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 845 | peak heights | Control MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 855 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 952 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 975 | peak heights | Control TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1016 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1054 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1143 | peak heights | TNT |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1287 | peak heights | MHC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1397 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1507 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1597 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1599 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1698 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1720 | peak heights | QC |
Reversed phase POSITIVE ION MODE | Gal-Gal-Cer(d18:1_16:0) or Lactosylceramide(d18:1_16:0) | 1843 | peak heights | QC |